Early Use of Mepolizumab Helps a Heart Attack Patient with Rare Allergy‑Related Disease
A patient who had severe heart attacks caused by a rare allergic inflammation called eosinophilic granulomatosis with polyangiitis (EGPA) was treated early with the drug mepolizumab. The condition, which involves high levels of a white‑blood‑cell type called eosinophils, can attack the blood vess